NGL Fine-Chem informs about revised investor presentation

28 May 2024 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that it enclosed Revised Investor Presentation for the quarter and year ended March 31, 2024. The earlier Investor Presentation had some errors in financials which are now been rectified.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

1799.50 -5.50 (-0.30%)
22-Nov-2024 12:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.00
Dr. Reddys Lab 1204.20
Cipla 1483.00
Lupin 2057.70
Zydus Lifesciences 945.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.